Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Monash IVF charts steady recovery after turbulent year
    • News

    Monash IVF charts steady recovery after turbulent year

    Fertility services provider Monash IVF Group (ASX: MVF) says it is on a path back to stability after a tumultuous year marked by an IVF laboratory incident that triggered executive turnover, dented patient confidence and weighed on earnings. The company reported first-half FY26 revenue of $137.9 million, down 1.8% on the prior corresponding period, and

    Read More
    Public
  • Capral sees lift in sales and outlook as with Government push for new home builds
    • News

    Capral sees lift in sales and outlook as with Government push for new home builds

    Aluminium products company Capral (ASX: CAA) has posted higher earnings for FY25, positioning itself for further growth as early signs of a recovery in new home construction begin to flow through to demand for aluminium products. Australia’s largest extruder and distributor of aluminium reported revenue of $686 million for the 12 months to 31 December 2025,

    Read More
    Public
  • Tabcorp delivers double-digit earnings growth as cost cutting offsets soft sports wagering
    • News

    Tabcorp delivers double-digit earnings growth as cost cutting offsets soft sports wagering

    Tabcorp (ASX: TAH) has delivered a steady first-half performance for FY26, posting double-digit earnings growth despite challenging conditions across Australia’s highly competitive wagering market. The wagering and media group reported revenue of $1.34 billion for the six months to 31 December 2025, up 1.0% on the prior corresponding period. Group EBITDA rose 14.3% to $217.4 million,

    Read More
    Public
  • Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    • News

    Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive

    After several challenging years for Australian retailers grappling with cost-of-living pressures and post-COVID inflation, eCommerce company Harris Technology (ASX: HT8) is emerging with renewed momentum, driven by the rapid scaling of its refurbished tech division. For the quarter ended 31 December 2025, The online retailer generated $4.4 million in sales revenue, up 16% on the

    Read More
    Public
  • Semtech and EMASS Bring Intelligence to the Edge as AI Meets Long-Range IoT
    • News

    Semtech and EMASS Bring Intelligence to the Edge as AI Meets Long-Range IoT

    Australia’s industrial and IoT sectors are racing toward smarter, more autonomous sensing and one of the clearest opportunities is at the extreme edge, where devices must operate on tiny batteries and stay connected across vast distances. That gap between intelligence and efficiency is exactly where Nanoveu’s (ASX:NVU) subsidiary EMASS and US-listed Semtech believe they can

    Read More
    Public
  • Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum
    • News

    Control Bionics Moves to Fully Acquire NeuroBounce Program as EMG-Based Performance Tech Gains Momentum

    As interest in neuromuscular activation tools accelerates across elite sport, Control Bionics Limited (ASX:CBL) is positioning itself to capture a growing performance market by moving to acquire full ownership of Neuro Elite Athletics, the U.S. group behind the NeuroBounce program. The company has been building an adjacent footprint in athletic performance through electromyography (EMG)-driven technology,

    Read More
    Public
  • «
  • ‹
  • 6
  • 7
  • 8
  • 9
  • 10
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.